VG, will partnerships include language of running a combo therapy with current/near future Alz SOC? Anavex has some data and insight into this area as they have not excluded anyone on these drugs.
So many questions so little time, who ill flinch first, BP or shorts? One thing is for sure and that is that Dr. Missling is calm as a cucumber and in total control sitting on the IP for possibly the largest drug to ever hit the market.
News 
Market Data 
Discover 
